MSP Recovery, Inc.’s supplement lists up to 909,982 Class A shares for resale, up to 755,200,000 warrants to purchase Class A shares, and up to 236,019 Class A shares issuable upon warrant exercise.
The attached report describes funding under letters with Hazel Partners Holdings, LLC, including $0.35 million funded on or about September 9, 2026, and four one-time advances from VRM MSP Recovery Partners, LLC for operational expenses. Hazel’s advances are discretionary and do not reopen facility availability; MSP Recovery said no additional funding was currently available under the facility. Directors Michael F. Arrigo and Beatriz Assapimonwait resigned from the board and their committees, effective immediately.
MSP Recovery, Inc. (MSPR) supplements its prospectus for the resale by selling securityholders of up to 32,220 Class A common shares, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at $0.4375 per share. MSP Recovery says it would receive only nominal proceeds if the warrant is exercised.
During September 2026, Hazel and VRM funded one-time advances to MSP Recovery. Hazel advances are discretionary and subject to conditions, including the absence of a default; the company says no additional funding is currently available under the Working Capital Credit Facility and it has no reasonable basis to expect further advances. VRM advances are for operating expenses and do not imply further advances. Directors Michael F. Arrigo and Beatriz Assapimonwait stepped down effective immediately on September 24, 2026, and September 28, 2026, respectively; the company said their resignations were not related to disagreements over its operations, policies, or practices.
MSP Recovery, Inc. (MSPR) has a resale prospectus covering up to 56,896 shares of Class A common stock offered by selling securityholders. The shares include up to 28,572 issuable upon exercise of VRM warrants; 2,858 already issued to VRP and up to 14,286 issuable upon exercise of a VRP warrant; and 11,180 issued to Palantir for products and services. MSP Recovery would receive only nominal proceeds if either warrant is exercised at $0.0175 per share. Its securities do not have an active public trading market, and Expert Market quotations are not publicly available.
Separately, the company disclosed one-time advances from Hazel and VRM. The Hazel advances do not reopen the facility’s availability, and the company said it has no rights to or reasonable basis to expect further funding under that facility. VRM’s advances are also described as one-time and do not obligate VRM to provide more. Directors Michael F. Arrigo and Beatriz Assapimonwait resigned effective immediately after notifying the company on September 24, 2026 and September 28, 2026, respectively.
MSP Recovery, Inc.’s prospectus covers the resale by Yorkville of up to 285,715 shares of Class A common stock that MSP Recovery may issue and sell to Yorkville under the Yorkville SEPA. MSP Recovery receives no proceeds from Yorkville’s resales, but expects proceeds from any shares it elects to sell directly to Yorkville. Those sales are priced, at the company’s election, at either 98% of Market Price or 97% of the lowest daily VWAP over three consecutive trading days.
A separate September 2026 disclosure says Hazel funded one-time advances of $0.06 million, $0.35 million, $0.03 million, $0.11 million, $0.06 million, $0.04 million and $0.04 million. These advances do not reopen facility availability, and no additional funding is currently available under the working-capital facility. VRM also funded one-time advances of $0.03 million, $0.03 million, $0.02 million and $0.04 million for operational expenses. Directors Michael F. Arrigo and Beatriz Assapimonwait resigned effective immediately on September 24 and September 28, 2026, respectively; the company said their resignations did not result from disagreements about its operations, policies or practices.
MSP Recovery, Inc., through subsidiaries, received one-time advances under its working capital credit facility from Hazel Partners Holdings, LLC. The Hazel agreements state individual funded amounts of $0.06 million, $0.35 million, $0.03 million, $0.11 million, $0.06 million, $0.04 million and $0.04 million. The narrative calls them six advances while describing seven dated agreements. Proceeds may be used only as approved by a majority of the Borrower’s Operating Committee members, and funding was subject to conditions including the absence of any event of default or default at funding.
MSP Recovery says the advances do not restore facility availability or commit Hazel to future funding; no other facility funding is currently available, and the company cautions the advances do not indicate its ability to meet operating or debt-service obligations beyond this specific funding. Separately, VRM MSP Recovery Partners, LLC funded one-time advances of $0.03 million, $0.03 million, $0.02 million and $0.04 million for operational expenses, without an obligation to provide further advances. Directors Michael F. Arrigo and Beatriz Assapimonwait stepped down from the Board and its committees effective immediately on September 24, 2026 and September 28, 2026, respectively; the company said their resignations did not result from disagreement over its operations, policies or practices.
MSP Recovery, Inc. (MSPR) filed a prospectus supplement tied to its Form S-1, covering the potential resale by selling securityholders of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the company’s potential issuance of up to 236,019 shares upon warrant exercise. Its common stock and warrants are quoted on the OTC Markets Group’s Expert Market and do not have an active public trading market, so current closing prices are not publicly available. The company previously effected a 1-for-7 reverse stock split effective September 1, 2025, and share data here reflects that adjustment. An attached report describes small, one-time funding arrangements for operating expenses under a discretionary working capital facility and from VRM MSP Recovery Partners, LLC, and states that these do not create committed or ongoing liquidity or any reasonable basis to expect further advances.
MSP Recovery, Inc. (MSPR) filed a prospectus supplement registering for resale up to 285,715 shares of Class A Common Stock that may be issued to YA II PN, Ltd. (Yorkville) under a $250 million Standby Equity Purchase Agreement. Shares sold to Yorkville are priced at 97–98% of VWAP, subject to a $0.50 floor and a 9.99% beneficial ownership cap. The prior 19.99% exchange cap has been lifted by stockholder approval.
The company has issued multiple Convertible Notes to Yorkville totaling $15.75 million in principal, generally bearing 5.0% interest (up to 18.0% on default) and maturing on November 30, 2026, with conversion at the lower of fixed prices per note or 95% of the lowest seven-day VWAP, but not below the $0.50 floor. MSP Recovery effected a 1‑for‑7 reverse stock split on September 1, 2025 and its securities now trade only on OTC venues with no active public trading market.
The attached Form 8‑K describes very small, one-time liquidity measures: Hazel Partners Holdings LLC provided two discretionary $0.03 million advances each (total $0.06 million) under a working capital credit facility, and VRM MSP Recovery Partners, LLC provided two $0.03 million recovery‑proceeds advances (total $0.06 million). The company states the facility offers no committed liquidity, no remaining availability beyond these amounts, and “no reasonable basis to expect” further advances.
MSP Recovery, Inc. (MSPR) filed a prospectus supplement registering for resale up to 32,220 shares of Class A common stock held by selling securityholders, including 15,239 shares issuable upon exercise of a CPIA Warrant at $0.4375 per share, from which the company would receive only nominal proceeds if exercised.
The company’s common stock and warrants are quoted on the OTC Markets Group’s Expert Market and lack an active public trading market, so current closing prices are not publicly available. A 1-for-7 reverse stock split of common stock became effective at 11:59 PM EDT on September 1, 2025, and share data in this supplement reflect that adjustment.
MSP Recovery also reports new short-term financing: Hazel Partners Holdings LLC provided two discretionary advances of $0.03 million each under a working capital facility, and VRM MSP Recovery Partners, LLC provided two one-time advances of $0.03 million each, all for operating expenses. These are standalone accommodations; the company states it has no rights to, and no reasonable basis to expect, any further advances under the Hazel facility and that the agreements do not provide access to ongoing liquidity.
MSP Recovery, Inc. (MSPR) filed a prospectus supplement covering the potential resale by selling securityholders of up to 56,896 shares of Class A common stock. This includes 28,572 shares issuable upon exercise of low-priced VRM warrants, 2,858 issued shares and 14,286 warrant shares for VRP, and 11,180 shares issued to Palantir for products and services. The company would receive only nominal proceeds from warrant exercises at an exercise price of $0.0175 per share, and receives no proceeds from resale transactions.
The filing also attaches a Form 8-K describing new short-term funding arrangements. Hazel Partners Holdings LLC provided two discretionary advances of $0.03 million each under an existing working capital credit facility, and VRM MSP Recovery Partners, LLC provided two one-time advances of recovery proceeds of $0.03 million each, all primarily for operating expenses. The company states that these are standalone accommodations, the facility remains fully discretionary, and there is currently no additional committed or expected funding available under the facility or from VRM.
MSP Recovery, Inc. (MSPR) reports entering several small, one‑time funding arrangements to cover operating expenses, while emphasizing that its main working capital facility remains fully discretionary and provides no committed liquidity.
Through subsidiaries, the company agreed with Hazel Partners Holdings LLC on an August 17, 2026 letter for a $0.03 million advance and an August 26, 2026 letter for an additional $0.03 million advance under the existing working capital credit facility’s Operational Collection Floor. Hazel funded these advances on August 18 and August 28, 2026, and the company notes aggregate prior advances under this mechanism had reached approximately $6.0 million as of its Q3‑2025 report. The company states these new advances are standalone accommodations, do not reopen availability under the facility, and do not create any ongoing funding commitment or borrowing base.
Separately, MSP Recovery entered a Third and Fourth Addendum with VRM MSP Recovery Partners, LLC, each providing a one‑time advance of recovery proceeds of $0.03 million, funded on August 14 and August 28, 2026, to be used only for operational expenses. The company cautions that neither Hazel nor VRM has any obligation to provide further advances and that these transactions should not be viewed as evidence of future funding or sufficient liquidity to meet operating or debt service obligations beyond the specific amounts funded.